「Telomerase reverse transcriptase promoter mutations in human hepatobiliary, pancreatic and gastrointestinal cancer cell lines」の関連論文
-
Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants
-
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
-
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
-
Identification of novel mutations and reassignment of archival xeroderma pigmentosum group C cell strains from Japanese patients
-
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
-
Mesenchymal stem cells induce tumor stroma formation and epithelial-mesenchymal transition through SPARC expression in colorectal cancer
-
Mesenchymal stem cells induce tumor stroma formation and epithelial-mesenchymal transition through SPARC expression in colorectal cancer
-
ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway
-
Association between microRNA‑527 and glypican‑3 in hepatocellular carcinoma
-
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
-
Genomic stability of mouse spermatogonial stem cells in vitro
-
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
-
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer
-
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer
-
PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study
-
PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Combination of RERG and ZNF671 methylation rates in circulating cell-free DNA: A novel biomarker for screening of nasopharyngeal carcinoma
-
The role of histone lysine demethylase 2B in the pathology of canine hemangiosarcoma
-
Neutrophil Extracellular Traps Promote Metastases of Colorectal Cancers through Activation of ERK Signaling by Releasing Neutrophil Elastase
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Growth and Migration Blocking Effect of Nanaomycin K, a Compound Produced by Streptomyces sp., on Prostate Cancer Cell Lines In Vitro and In Vivo
-
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
-
PCBP2 knockdown promotes ferroptosis in malignant mesothelioma
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
The role of GPNMB ectodomain in breast cancer development
-
Exploring the function and regulation of epithelial cell transforming sequence 2 in lung adenocarcinoma cells
-
Luteolin suppress bladder cancer growth via regulation of mechanistic target of rapamycin (mTOR) pathway
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Stanniocalcin-1 mRNA expression in soft-tissue tumors
-
GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas
-
Genetic screening for malignant hyperthermia and comparison of clinical symptoms in Japan
-
Genetic screening for malignant hyperthermia and comparison of clinical symptoms in Japan
-
Analyses of the Molecular Determinant of Cell Fate Induced by an Antimetabolite, Trifluridine
-
Serum amyloid alpha 1-2 are not required for liver inflammation in the 4T1 murine breast cancer model
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC
-
Osteogenic cocktail induces calcifications in human breast cancer cell line via placental alkaline phosphatase expression.
-
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells
-
Propofol elicits apoptosis and attenuates cell growth in esophageal cancer cell lines
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload
-
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
-
Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency
-
Similarities and differences in metabolites of tongue cancer cells among two- and three-dimensional cultures and xenografts.
-
The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells
-
Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition